ClinicalTrials.Veeva

Menu

Change in Stroke Volume Index After Diuresis for Patients With Decompensated Heart Failure

NYU Langone Health logo

NYU Langone Health

Status

Enrolling

Conditions

Acute Decompensated Heart Failure

Study type

Observational

Funder types

Other

Identifiers

NCT05240651
20-02048

Details and patient eligibility

About

This is a prospective cohort study for 50 patients admitted to the cardiac care unit requiring clinically-indicated diuretic therapy for congestive heart failure. The purpose of this study is to assess the role of non-invasive cardiac output monitoring (NICOM) with the Starling Fluid Management System (Baxter Medical, Deerfield, IL) in determining volume status in patients with acute decompensated heart failure requiring intravenous diuretic therapy.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Diagnosis of congestive acute decompensated heart failure (preserved or reduced ejection fraction) requiring clinically indicated IV diuresis
  2. Admission to coronary/cardiac intensive care unit or cardiac step down unit
  3. Able to provide written informed consent
  4. Anticipated need for IV diuretics > 24 hrs

Exclusion criteria

  1. Prisoner, pregnancy or post-partum stage, or age < 18 years
  2. Known allergy to sensory material or gel
  3. End stage renal disease or need for CRRT
  4. Inability or contraindication to do a passive leg raise with both extremities (i.e., balloon pump, impella, spinal injury, amputation)
  5. Other situation that might increase subject risk, interfere with study procedures, or confound study findings based on the opinion of the clinician/investigator
  6. Inability to provide informed consent

Trial contacts and locations

1

Loading...

Central trial contact

Carlos Alviar, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems